Modulation of CD4+ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis

Clinical and Experimental Immunology

Volumn 165, Issue 2, 2011, Pages 243-250

  Hashimoto, N ^a   Shimoda, S ^a   Kawanaka, H ^a   Tsuneyama, K ^b   Uehara, H ^a   Akahoshi, T ^a   Kinjo, N ^a   Taketomi, A ^a   Shirabe, K ^a   Akashi, K ^a   Lleo, A ^c   Ansari, A A ^d   Gershwin, M E ^e   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCV; Liver cirrhosis; PD 1; PD 1 ligand; Splenectomy

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; APOPTOSIS REGULATORY PROTEIN; B7 ANTIGEN; CD274 PROTEIN, HUMAN; CTLA4 PROTEIN, HUMAN; CYTOKINE; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN; PDCD1LG2 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LIVER CIRRHOSIS; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA; AGED; BIOSYNTHESIS; FLOW CYTOMETRY; GENETICS; HEPATITIS C; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VIROLOGY;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD274; ANTIGENS, CD80; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; CYTOKINES; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; SPLEEN; SPLENECTOMY;

EID: 80955178795     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04393.x     Document Type: Article

References (38)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-67.
3. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119:1745-54.
4. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 7:804-13.
5. Urbani S, Amadei B, Fisicaro P etal. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006; 44:126-39.
6. Hall CH, Kassel R, Tacke RS, Hahn YS. HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS ONE 2010; 5:e12154.
7. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 1966; 45:645-57.
8. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther 2007; 26 (Suppl. 1):13-19.
9. Chander G, Sulkowski MS, Jenckes MW etal. Treatment of chronic hepatitis C: a systematic review. Hepatology 2002; 36:S135-44.
10. Heathcote EJ. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 2004; 127:S294-302.
11. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362:2095-100.
12. Heathcote EJ, Shiffman ML, Cooksley WG etal. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000; 343:1673-80.
13. Zeuzem S, Feinman SV, Rasenack J etal. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 2000; 343:1666-72.
14. Hayashi PH, Mehia C, Joachim Reimers H, Solomon HS, Bacon BR. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol 2006; 40:740-4.
15. Davern TJ. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol 2008; 42:863-4.
16. Shimoda S, Harada K, Niiro H etal. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 2010; 51:567-75.
17. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005; 436:946-52.
18. Barber DL, Wherry EJ, Masopust D etal. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-7.
19. Fife BT, Pauken KE, Eagar TN etal. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009; 10:1185-92.
20. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005; 6:873-9.
21. Keir ME, Liang SC, Guleria I etal. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203:883-95.
22. Latchman Y, Wood CR, Chernova T etal. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2:261-8.
23. Boettler T, Spangenberg HC, Neumann-Haefelin C etal. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79:7860-7.
24. Cox AL, Mosbruger T, Mao Q etal. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005; 201:1741-52.
25. Wedemeyer H, He XS, Nascimbeni M etal. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169:3447-58.
26. Cabrera R, Tu Z, Xu Y etal. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004; 40:1062-71.
27. Ebinuma H, Nakamoto N, Li Y etal. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 2008; 82:5043-53.
28. Golden-Mason L, Klarquist J, Wahed AS, Rosen HR. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J Immunol 2008; 180:3637-41.
29. Shirakawa H, Matsumoto A, Joshita S etal. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 2008; 48:1753-60.
30. Kanto T, Hayashi N, Takehara T etal. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999; 162:5584-91.
31. Shiina M, Rehermann B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 2008; 47:385-95.
32. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6.
33. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
34. Ha SJ, Mueller SN, Wherry EJ etal. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008; 205:543-55.
35. Lukens JR, Cruise MW, Lassen MG, Hahn YS. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol 2008; 180:4875-84.
36. Pinchuk IV, Saada JI, Beswick EJ etal. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterology 2008; 135:1228-37, 37 e1-2.
37. Kassel R, Cruise MW, Iezzoni JC, Taylor NA, Pruett TL, Hahn YS. Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology 2009; 50:1625-37.
38. Rodig N, Ryan T, Allen JA etal. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003; 33:3117-26.